Photo by abeosorio from unsplash
Individuals with intellectual and/or developmental disability (IDD) are often prescribed antipsychotics (APs). However, despite their known propensity to cause metabolic adverse effects, including weight gain, diabetes, and increased risk of… Click to show full abstract
Individuals with intellectual and/or developmental disability (IDD) are often prescribed antipsychotics (APs). However, despite their known propensity to cause metabolic adverse effects, including weight gain, diabetes, and increased risk of cardiovascular events, there is currently a limited body of literature describing the metabolic consequences of AP use in this population.
Keywords:
intellectual developmental;
adverse effects;
individuals intellectual;
metabolic adverse;
developmental disability
Journal Title: Acta Psychiatrica Scandinavica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Psychiatrica Scandinavica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!